Connect Biopharma Holdings Ltd: Leerink Partners assumes coverage with outperform rating; target price $4
CNTB•Leerink Partners assumed coverage of Connect Biopharma Holdings Ltd with an outperform rating and a $4 target price.
Related News
Ardelyx reports real-world study shows lower GI-related healthcare visits after IBSRELA start in IBS-C patients
ARDX•
Streamex adds CNB Custody as qualified custodian for GLDY shares
STEX•
Vicor says USITC opens patent probe into vertical power delivery modules and computing systems
VICR•
Harmony Biosciences CEO Dayno to retire, COO to take over; shares fall
HRMY•
Alerts incorrectly tagged to DCX Systems withdrawn
DCX•